Health and Healthcare Systems

We could be one step closer to a cure for HIV

Nine-year-old Tumelo shows off antiretroviral (ARV) pills before taking his medication at Nkosi's Haven, south of Johannesburg November 28, 2014. Nkosi's Haven provides residential care for destitute HIV-positive mothers and their children, whether HIV-positive or not. Nkosi's Haven is named after Nkosi Johnson, the young AIDS activist who passed away on International Children's Day on June 1, 2001. December 1 is World AIDS Day. Picture taken November 28.  REUTERS/Siphiwe Sibeko (SOUTH AFRICA - Tags: HEALTH) - RTR4G62Y

The experimental therapy works in two stages. Image: REUTERS/Siphiwe Sibeko

Jess Vilvestre
Writer, Futurism
Kristin Houser
Writer, Futurism
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on Health and Healthcare Systems?
The Big Picture
Explore and monitor how Global Health is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Future of Global Health and Healthcare

A team of scientists from five universities in the UK may be close to finding a cure for HIV as their experimental drug treatments have caused the virus to vanish from a 44-year-old man’s blood. The patient, who preferred to remain anonymous, said, “My last blood test was a couple of weeks ago and there is no detectable virus.”

In an interview with The Sunday Times, Mark Samuels, Managing Director of the National Institute for Health Research Office for Clinical Research Infrastructure, said, “We are exploring the real possibility of curing HIV. This is a huge challenge and it’s still early days, but the progress has been remarkable.”

The current treatment for HIV is antiretroviral therapy (ART), a series of medications that suppress the growth of the virus. ART, however, cannot spot HIV-afflicted cells that have become dormant but may still reawaken to infect the patient. Professor Sarah Fidler, a consultant physician from Imperial College London, said, “This therapy is specifically designed to clear the body of all HIV viruses, including dormant ones.

The experimental therapy works in two stages. First, because the immune system doesn’t just ignore HIV, it helps the virus reproduce, the patient is treated with vaccines that help the body recognize the HIV-infected cells. Second, the drug Vorinostat is administered to activate the dormant cells so they can be spotted by the immune system.

HIV virus
Image: Seth Pincus Elizabeth Fisher Austin Athman National Institute of Allergy and Infectious Diseases

HIV continues to be a major global public health issue, having claimed more than 35 million lives so far, and the “cured” man is one of just 50 people currently undergoing this experimental therapy, a small percentage of the estimated 36.7 million people currently living with HIV, only 54 percent of whom know their status.

While the results of the treatment out of the UK are promising, those dormant T cells could still be lurking in the patient, so this new treatment can’t yet be considered a “cure.” However, it is another encouraging step forward on the path to one.

“We will continue with medical tests for the next five years and at the moment we are not recommending stopping Art but in the future, depending on the test results we may explore this,” said Fidlar

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Gender and health equity will only come with universal access to eye health – here's why

Dr. Princess Ifeoma Ike

May 24, 2024

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum